Recent insider trading activity from Bowen Matthew, including buys and sells reported to the SEC.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 6, 2026 | Monte Rosa Therapeutics, Inc. | $GLUE | Bowen Matthew | Principal Accounting Officer | A | Common Stock | 4300 | $0.00 | 25,904.0000 | 82,942,723 | 19.90% | 0.01% |
| April 6, 2026 | Monte Rosa Therapeutics, Inc. | $GLUE | Bowen Matthew | Principal Accounting Officer | A | Stock Option (Right to Buy) | 19500 | $0.00 | 19,500.0000 | 82,942,723 | 9999.99% | 0.02% |